2023-10-04 10:25:45
ELI LILLY (I4V-MC-JAJA) – Latin Clinical Trial Center

ELI LILLY (I4V-MC-JAJA)

By June 19, 2019 Active/Enrolling

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis

Join the discussion 47 Comments

Leave a Reply